Adagio Medical Holdings ADGM Growth Metrics (2023-2026)

NASDAQ ADGM
$0.12 -0.01 (-4.55%)
At close: Oct 21, 2026 · 4:00 PM EDT
Reported Financials

Adagio Medical Holdings Quarterly Growth Metrics

Periods 11 quarters
Latest Jun 2026

Adagio Medical Holdings reported asset growth of -5.55% for the quarter ended Jun 2026. These growth metrics cover 11 quarters of results from Dec 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Assets Growth (1y) 609.86%-70.57%-10.72%-4.91%-5.55%
Assets (QoQ) -54.80%-14.68%-13.21%-12.07%37.11%-9.12%-13.80%
Capital Expenditures Growth (1y)Capex Growth (1y) 106.79%-99.40%-40.00%
Capital Expenditures (QoQ)Capex (QoQ) 710.00%-97.01%100.41%200.00%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) 1,389.52%-83.39%-16.97%-0.70%-5.61%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ) -27.21%-36.89%-36.92%-42.68%263.94%-24.53%-40.04%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y) -106.79%99.40%40.00%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ) -710.00%97.01%-100.41%-200.00%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y) -7.00%42.78%-12.48%
Cash from Operations (QoQ)Cash from Ops. (QoQ) 5.08%34.97%-0.29%-27.82%
EBITDA Margin Growth (1y) 1.88M
EBITDA Margin (QoQ) 1.52M-2.60M3.01M-0.06M
EBIT Growth (1y) 51.27%16.09%29.16%-29.29%29.70%-4.60%
EBIT Margin Growth (1y) 1.88M
EBIT Margin (QoQ) 1.53M-2.71M3.13M-0.07M
EBIT (QoQ) 41.27%-65.29%24.46%33.55%36.23%-21.28%30.64%-31.05%5.12%
EBT Growth (1y) 50.92%17.49%28.07%-36.15%25.64%-6.22%
EBT Margin Growth (1y) 1.98M
EBT Margin (QoQ) 1.58M-2.92M3.39M-0.06M
EBT (QoQ) 38.22%-61.92%22.48%36.71%32.43%-19.79%27.85%-27.33%3.47%
EPS (Basic) Growth (1y) 101.81%95.12%96.51%-356.44%37.17%-17.86%
EPS (Basic) (QoQ) 19.83%9.50%28.49%103.49%48.85%-156.35%57.71%-13.31%4.04%
EPS (Diluted) Growth (1y) 101.58%95.25%96.60%-392.92%37.17%-17.86%
EPS (Diluted) (QoQ) 19.79%7.10%28.49%102.97%48.85%-156.35%57.71%-13.31%4.04%
FCF Margin (QoQ) -1.74M
Free Cash Flow Growth (1y)FCF Growth (1y) -9.35%45.30%-12.36%
Free Cash Flow (QoQ)FCF (QoQ) 3.08%37.73%-13.94%-27.91%
Gross Margin Growth (1y) 0.03M
Gross Margin (QoQ) 0.02M-0.17M0.18M0.00M
Gross Profit Growth (1y) -33.02%50.97%20.09%89.01%
Gross Profit (QoQ) -20.75%-101.56%17.05%34.11%-35.18%90.94%-87.10%
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y) 45.67%4.42%25.23%24.91%40.18%6.44%
Interest Coverage Ratio (QoQ)Interest Cover (QoQ) 50.64%-26.49%25.05%-16.10%41.37%-16.59%32.97%-30.54%8.30%
Net Cash Flow Growth (1y)NCF Growth (1y) -382.62%-192.65%45.30%-12.36%
Net Cash Flow (QoQ)NCF (QoQ) 592.62%89.96%-237.58%37.73%-13.94%-27.91%
Net Income Growth (1y) 137.70%3.80%46.78%-277.23%9.31%-70.18%
Net Income (QoQ) 9.86%6.99%7.50%148.62%48.83%-61.92%48.27%-111.58%3.97%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y) 133.51%3.80%31.16%-380.59%9.24%-70.18%
Net Income towards Common Stockholders (QoQ)Net Income (QoQ) 19.79%7.10%28.49%162.89%48.83%-156.35%54.43%-51.81%4.04%
Net Margin Growth (1y) 2.90M
Net Margin (QoQ) 1.52M-1.98M2.86M0.50M
Operating Income Growth (1y)Op. Inc Growth (1y) 51.27%16.09%29.16%-29.29%29.70%-4.60%
Operating Income (QoQ)Op. Inc (QoQ) 41.27%-65.29%24.46%33.55%36.23%-21.28%30.64%-31.05%5.12%
Operating Margin Growth (1y) 1.88M
Operating Margin (QoQ) 1.53M-2.71M3.13M-0.07M
Profit After Tax Growth (1y)PAT Growth (1y) 50.92%17.49%28.07%-36.15%25.64%-6.22%
Profit After Tax (QoQ)PAT (QoQ) 38.22%-61.92%22.48%36.71%32.43%-19.79%27.85%-27.33%3.47%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y) 31.88%8.21%-21.72%-36.69%-40.12%
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ) 24.75%6.73%-10.08%-9.62%-9.76%-13.68%-14.94%
Return on Assets [ROA] Growth (1y)ROA Growth (1y) 0.00M405.00
Return on Assets [ROA] (QoQ)ROA (QoQ) 24.00-649.00734.000.00M-779.00
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y) 0.00M51.00
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ) 140.000.00M0.00M0.00M-833.00
Return on Equity [ROE] Growth (1y)ROE Growth (1y) -0.01M-0.06M
Return on Equity [ROE] (QoQ)ROE (QoQ) -0.01M-0.04M0.02M0.02M-0.06M
Return on Sales [ROS] Growth (1y)ROS Growth (1y) 1.88M2.73M-0.34M-1.35M
Return on Sales [ROS] (QoQ)ROS (QoQ) 1.53M-2.71M3.13M-0.07M0.06M-1.09M
Revenue Growth (1y) 221.95%
Revenue (QoQ) 90.24%-66.67%876.92%-48.03%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y) 98.18%110.81%78.44%104.70%
Share-based Compensation (QoQ)Stock Comp. (QoQ) -2.65%0.91%7.34%-41.45%549.64%-56.29%23.14%
Total Debt Growth (1y) -57.99%
Total Debt (QoQ) 16.92%

Adagio Medical Holdings Growth Metrics API

Pull Adagio Medical Holdings's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ADGM&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY